Related Experiment Video
Updated: Apr 18, 2026
06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
2.1K
Prostate-specific membrane antigen-based imaging in prostate cancer: impact on clinical decision making process
Mehmet Onur Demirkol1, Ömer Acar, Burcu Uçar
1Koc University, School of Medicine, Department of Nuclear Medicine and Molecular Imaging, Istanbul, Turkey; VKF American Hospital, Department of Nuclear Medicine and Molecular Imaging, Istanbul, Turkey.
The Prostate
|January 20, 2015
Summary
Prostate-specific membrane antigen (PSMA) PET/CT imaging shows promise for detecting prostate cancer lesions, even at low PSA levels. This nuclear imaging technique is impacting disease management and warrants further clinical investigation.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiochemistry
Background:
- Accurate imaging is crucial for prostate cancer management, including staging, metastasis detection, and recurrence investigation.
- Prostate-specific membrane antigen (PSMA) is a promising molecular target for prostate cancer-specific nuclear imaging.
- This study evaluates initial results of PSMA-based PET/CT imaging in prostate cancer patients.
Purpose of the Study:
- To evaluate the initial results of PSMA-based PET/CT imaging in prostate cancer.
- To assess the impact of Ga-68 PSMA PET/CT findings on disease management.
- To investigate the utility of PSMA imaging in various clinical scenarios.
Main Methods:
- Retrospective review of 22 patients who underwent Ga-68 PSMA PET/CT between February and August 2014.
- Analysis of clinical characteristics, indications for imaging, and results.
- Documentation of the impact of imaging findings on subsequent disease management.
Main Results:
- Common indications included rising PSA post-treatment, staging, and metastatic evaluation.
- PSMA-positive lesions were detected in the prostate or extraprostatic sites in 20 out of 22 patients.
- No negative PSMA imaging results were observed in patients with PSA levels above 2 ng/ml.
Conclusions:
- PSMA-based nuclear imaging significantly influences prostate cancer patient management.
- The preliminary performance of PSMA imaging in detecting lesions, even at low PSA values, is promising.
- Further clinical studies are warranted to supplement these findings.
